多原发恶性肿瘤(甲状腺乳头状癌与恶性黑色素瘤) 1例
A Case Report of Multiple Primary Neoplasms: Papillary Thyroid Carcinoma Combined with Malignant Melanoma
摘要: 多原发恶性肿瘤(Multiple primary neoplasms, MPNs)在临床上的发病情况极为罕见,我国MPNs的发病率约0.60%~2.67%。MPNs的诊断与治疗对于临床医生来说均是极具挑战性的难题。本文现报道1例50岁女性患者,其被同步诊断为甲状腺乳头状癌与恶性黑色素瘤,且伴有全身多处区域淋巴结转移。本文结合患者的临床资料、病变组织形态学特征以及免疫组化结果,对相关文献进行复习,分析该类病例的发病特点与诊疗进展,旨在为临床病理医师的诊断工作以及临床治疗方案的制定提供参考,同时丰富该类病例的临床病理资料。
Abstract: Multiple primary neoplasms (MPNs) are extremely rare in clinical practice. The incidence of MPNs in China is approximately 0.60% to 2.67%. The diagnosis and treatment of MPNs present significant challenges for clinicians. This paper reports the case of a 50-year-old female patient who was concurrently diagnosed with papillary thyroid carcinoma and malignant melanoma, accompanied by multiple regional lymph node metastases throughout the body. Based on the integration of the patient’s clinical data, morphological characteristics of the lesional tissue, and immunohistochemistry findings, this study reviews the relevant literature and conducts an in-depth analysis of the clinical features, diagnosis, and therapeutic advancements in this category of cases. The objective is to provide valuable insights to support diagnostic practices for clinical pathologists and inform the formulation of treatment strategies, while also contributing to the enrichment of clinicopathological documentation for such cases.
文章引用:陈君玉, 李维轩, 江怡如, 张博琳, 刘四君. 多原发恶性肿瘤(甲状腺乳头状癌与恶性黑色素瘤) 1例[J]. 临床医学进展, 2026, 16(3): 3720-3727. https://doi.org/10.12677/acm.2026.1631179

参考文献

[1] 中国抗癌协会多原发和不明原发肿瘤整合康复专业委员会, 陕西省抗癌协会罕见肿瘤专业委员会. 多原发肿瘤诊治中国专家共识(2024版) [J]. 中华消化外科杂志, 2024, 23(10): 1261-1276.
[2] Kim, C.Y., Lee, S.H. and Oh, C.W. (2010) Cutaneous Malignant Melanoma Associated with Papillary Thyroid Cancer. Annals of Dermatology, 22, 370-372. [Google Scholar] [CrossRef] [PubMed]
[3] Ozgun, A., Tuncel, T., Emirzeoglu, L., Celik, S., Bilgi, O., Haholu, A., et al. (2015) Malignant Melanoma and Papillary Thyroid Carcinoma That Were Diagnosed Concurrently and Treated Simultaneously: A Case Report. Oncology Letters, 9, 468-470. [Google Scholar] [CrossRef] [PubMed]
[4] 陈佳, 徐峰, 王海峰, 等. 乳房原发性恶性黑色素瘤伴复发转移1例[J]. 浙江医学, 2023, 45(20): 2212-2213.
[5] Hines, A.S., Campbell, E.H., Reinhart, J.P., Crum, O.M., Proffer, S.L., Brewer, J.D., et al. (2024) Primary Cutaneous Melanoma of the Breast Skin: Incidence, Characteristics, and Management. JAAD International, 17, 15-16. [Google Scholar] [CrossRef] [PubMed]
[6] 中华人民共和国国家卫生健康委员会. 甲状腺癌诊疗指南(2022年版) [J]. 中国实用外科杂志, 2022, 42(12): 1343-1357.
[7] 孙海林, 武振, 崔兆清. 甲状腺癌病因学研究现状[J]. 中华普通外科杂志, 2025, 40(4): 325-328.
[8] 张滢, 梁楠, 孙辉. 基因变异在儿童与成人甲状腺乳头状癌生物学行为差异中的作用[J]. 中国实用外科杂志, 2023, 43(2): 226-230.
[9] 中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)黑色素瘤诊疗指南[M]. 北京: 人民卫生出版社, 2019: 70.
[10] Schadendorf, D., Fisher, D.E., Garbe, C., Gershenwald, J.E., Grob, J., Halpern, A., et al. (2015) Melanoma. Nature Reviews Disease Primers, 1, Article No. 15003. [Google Scholar] [CrossRef] [PubMed]
[11] Schadendorf, D., van Akkooi, A.C.J., Berking, C., Griewank, K.G., Gutzmer, R., Hauschild, A., et al. (2018) Melanoma. The Lancet, 392, 971-984. [Google Scholar] [CrossRef] [PubMed]
[12] Goggins, W., Daniels, G.H. and Tsao, H. (2006) Elevation of Thyroid Cancer Risk among Cutaneous Melanoma Survivors. International Journal of Cancer, 118, 185-188. [Google Scholar] [CrossRef] [PubMed]
[13] Soares, P., Trovisco, V., Rocha, A.S., Lima, J., Castro, P., Preto, A., et al. (2003) BRAF Mutations and RET/PTC Rearrangements Are Alternative Events in the Etiopathogenesis of PTC. Oncogene, 22, 4578-4580. [Google Scholar] [CrossRef] [PubMed]
[14] Tan, M., Mester, J.L., Ngeow, J., Rybicki, L.A., Orloff, M.S. and Eng, C. (2012) Lifetime Cancer Risks in Individuals with Germline PTEN Mutations. Clinical Cancer Research, 18, 400-407. [Google Scholar] [CrossRef] [PubMed]
[15] Asharaff, F., Schirwani, S. and Lachlan, K. (2025) SG04 Early-Onset Superficial Spreading Melanoma and Macrocephaly: Think Cowden Syndrome. British Journal of Dermatology, 193, ljaf85-ljaf513. [Google Scholar] [CrossRef
[16] Taibo, A., Paradela, S., Suanzes-Hernández, J., Balboa-Barreiro, V., Amado-Bouza, J. and Fonseca, E. (2024) Prognosis of CDKN2A Germline Mutation in Patients with Familial Melanoma: A Systematic Review and Meta-Analysis. Melanoma Research, 34, 9-15. [Google Scholar] [CrossRef] [PubMed]
[17] Foppiani, L., Forzano, F., Ceccherini, I., Bruno, W., Ghiorzo, P., Caroli, F., et al. (2008) Uncommon Association of Germline Mutations of RET Proto-Oncogene and CDKN2A Gene. European Journal of Endocrinology, 158, 417-422. [Google Scholar] [CrossRef] [PubMed]
[18] Zeng, H., Zheng, R., Sun, K., Zhou, M., Wang, S., Li, L., et al. (2024) Cancer Survival Statistics in China 2019-2021: A Multicenter, Population-Based Study. Journal of the National Cancer Center, 4, 203-213. [Google Scholar] [CrossRef] [PubMed]